» Articles » PMID: 37713884

Risk Factors for Distant Metastasis of Chondrosarcoma: A Population-based Study

Overview
Specialty General Medicine
Date 2023 Sep 15
PMID 37713884
Authors
Affiliations
Soon will be listed here.
Abstract

Chondrosarcoma is the second largest bone malignancy after osteosarcoma and mainly affects middle-aged adults, where patients with distant metastasis (DM) often have a poor prognosis. Although nomograms have been widely used to predict distant tumor metastases, there is a lack of large-scale data studies for the diagnostic evaluation of DM in chondrosarcoma. Data on patients diagnosed with chondrosarcoma from 2004 to 2015 were obtained from the Surveillance, Epidemiology, and End Results database. Independent risk factors for having DM from chondrosarcoma were screened using univariate and multivariate logistics regression analysis. A nomogram was created to predict the probability of DM from the screened independent risk factors. The nomogram was then validated using receiver operating characteristic curves and calibration curves. A total of 1870 chondrosarcoma patients were included in the study after data screening, of which 157 patients (8.40%) had DM at the time of diagnosis. Univariate and multivariate logistic regression analysis screened four independent risk factors, including grade, tumor number, T stage, and N stage. receiver operating characteristic curves and calibration curves showed good accuracy of the nomogram in both training and validation sets. The current study screened for independent risk factors for DM from chondrosarcoma, which will help clinicians evaluate patients.

References
1.
Gelderblom H, Hogendoorn P, Dijkstra S, van Rijswijk C, Krol A, Taminiau A . The clinical approach towards chondrosarcoma. Oncologist. 2008; 13(3):320-9. DOI: 10.1634/theoncologist.2007-0237. View

2.
Chen B, Zeng Y, Liu B, Lu G, Xiang Z, Chen J . Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study. Front Endocrinol (Lausanne). 2021; 12:672024. PMC: 8362092. DOI: 10.3389/fendo.2021.672024. View

3.
Chen H, Liu J, Cheng Z, Lu X, Wang X, Lu M . Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study. Eur J Radiol. 2020; 129:109066. DOI: 10.1016/j.ejrad.2020.109066. View

4.
Hua K, Hu Y . Treatment method and prognostic factors of chondrosarcoma: based on Surveillance, Epidemiology, and End Results (SEER) database. Transl Cancer Res. 2022; 9(7):4250-4266. PMC: 8798983. DOI: 10.21037/tcr-20-357. View

5.
Guder W, Hardes J, Gosheger G, Nottrott M, Streitburger A . [Osteosarcoma and chondrosarcoma of the pelvis and lower extremities]. Chirurg. 2015; 86(10):993-1003. DOI: 10.1007/s00104-015-0082-0. View